PCI Biotech: Mandatory notification of trade

The board member Theresa Comiskey Olsen has today, 2nd February 2015, subscribed
for 13,659 new shares in PCI Biotech Holding ASA (the "Company") at a
subscription price of NOK 10 per share by exercising 13,659 subscription rights
in the Company's ongoing rights issue. Related party to Theresa Comiskey Olsen
has subscribed, through the company Sognefjell AS, for 10,977 new shares in the
rights issue at a subscription price of NOK 10 per share by exercising 10,977
subscription rights in the Company's ongoing rights issue. After the transaction
Theresa Comiskey Olsen and related parties have a total shareholding in the
Company of 51,829 shares and 0 subscription rights.

This information is subject to the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.



[HUG#1891213]